1. Home
  2. SPRO vs BTOC Comparison

SPRO vs BTOC Comparison

Compare SPRO & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.34

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.70

Market Cap

43.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
BTOC
Founded
2013
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.7M
43.6M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
SPRO
BTOC
Price
$2.34
$0.70
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
328.9K
427.5K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,549,000.00
$197,399,541.00
Revenue This Year
N/A
$34.89
Revenue Next Year
N/A
$14.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.35
52 Week Low
$0.51
$0.41
52 Week High
$3.22
$5.84

Technical Indicators

Market Signals
Indicator
SPRO
BTOC
Relative Strength Index (RSI) 49.98 63.05
Support Level $2.26 $0.56
Resistance Level $2.39 $0.68
Average True Range (ATR) 0.08 0.05
MACD -0.00 0.02
Stochastic Oscillator 62.50 88.46

Price Performance

Historical Comparison
SPRO
BTOC

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

Share on Social Networks: